Pharmaceuticals Analyst Karnauskas discusses Vertex’s VX-548 and other acute and longer-acting pain drugs on an Analyst/Industry conference call to be held on April 3 at 10 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRTX:
- Vertex Pharmaceuticals announces FDA clearance of VX-407 IND
- William Blair biotech analysts to hold an analyst/industry conference call
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Vertex Pharmaceuticals participates in a conference call with JPMorgan
- Vertex Pharmaceuticals downgraded to Buy from Conviction Buy at Goldman Sachs
